June 3, 2020
Prilenia Therapeutics Raises $62.5m to Fund Late Stage Trials in HD and ALS
NAARDEN, Netherlands & HERZLIYA, Israel–(BUSINESS WIRE)–Prilenia Therapeutics B.V., a clinical stage biotech company focused on developing novel treatments for neurodegenerative…